Menu

IMA Clinical Research - St. Petersburg

St. Petersburg, Florida United States

Claim This Site

Are you the site administrator? Claim this site to update information.

12Total Trials
2Recruiting Trials
5Active Trials
6Completed Trials
15Unique Conditions
9Unique Sponsors

Conditions

Obesity (4)Overweight (3)Atopic Dermatitis (2)Cardiovascular Diseases (1)Chronic Low Back Pain (CLBP) (1)Diabetes Mellitus, Type 2 (1)Diabetic Peripheral Neuropathic Pain (1)Gout (1)

Sponsors

Eli Lilly and Company (3)ModernaTX, Inc. (2)Amgen (1)Arena Pharmaceuticals (1)Boehringer Ingelheim (1)Ionis Pharmaceuticals, Inc. (1)LG Chem (1)Reata, a wholly owned subsidiary of Biogen (1)

Affiliations

Associated Organizations

Basic Information

Site Overview

IMA Clinical Research is a US-based clinical research network that conducts site-based, hybrid, and decentralized clinical trials across multiple therapeutic areas. The organization partners with sponsors and CROs to support the development of new medical treatments through a nationwide network of clinical research sites and more than 150 satellite locations. Its operations focus on broad patient access, diversity in recruitment, and technology-enabled trial delivery models. The company maintains a patient database of over 400,000 participants and reports access to more than 10,000 unique patient visits weekly. IMA Clinical Research conducts studies in areas including cardiology, neurology, psychiatry, endocrinology, infectious diseases, obesity, vaccines, dermatology, and metabolic disorders. The organization also emphasizes patient outreach, centralized contracting, and regulatory compliance to improve enrollment, retention, and study efficiency.

Accessibility & Parking

Accessibility Features

Wheelchair accessible entrance
Wheelchair accessible parking lot
Wheelchair accessible restroom
Wheelchair accessible seating